Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B‐cell lymphoma

Published:2015-02 Issue:2 Volume:106 Page:186-193
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Tateishi Ukihide¹,Tatsumi Mitsuaki²,Terauchi Takashi³,Ando Kiyoshi⁴,Niitsu Nozomi⁵,Kim Won Seog⁶,Suh Cheolwon⁷,Ogura Michinori⁸,Tobinai Kensei⁹

Affiliation:

1. Department of Diagnostic Radiology and Nuclear Medicine Tokyo Medical and Dental University Graduate School of Medicine TokyoJapan

2. Department of Radiology Osaka University Graduate School of Medicine OsakaJapan

3. Division of Diagnostic Radiology National Cancer Center Hospital TokyoJapan

4. Department of Hematology and Oncology Tokai University Hospital KanagawaJapan

5. Department of Hematology Saitama Medical University International Medical Center Saitama Japan

6. Hematology–Oncology Samsung Medical Center Seoul Republic of Korea

7. Hematology–Oncology Asan Medical Center Seoul Republic of Korea

8. Department of Hematology and Oncology Nagoya Daini Red Cross Center Hospital NagoyaJapan

9. Department of Hematology National Cancer Center Hospital Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12588

Reference32 articles.

1. Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin’s lymphoma6

2. Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy

4. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

5. Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of 18F-FDG PET/CT findings on prognosis in patients with diffuse large B cell lymphoma;Journal of Health Sciences and Medicine;2023-10-29

2. Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma;EJNMMI Research;2023-07-26

3. Radiomics Predictive Modeling from Dual-Time-Point FDG PET Ki Parametric Maps: Application to Chemotherapy Response in Lymphoma;2023-06-16

4. Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques;Cancers;2023-03-23

5. Imaging glucose metabolism to reveal tumor progression;Frontiers in Physiology;2023-02-02